Lu Guo
15 Papers
Lu Guo is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 11 publications.
Chat about Author
Papers
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study
Ke Su,Lu Guo,Wenqiong Ma,Jing Wang,Yunchuan Xie,Mingyue Rao,Jianwen Zhang,Xueting Li,Lian Xiao Wen,Bo Li,Xiaoli Yang,Yan-Hong Song,Weihong Huang,Hao Chi,T. Gu,Ke Xu,Yanlin Liu,Jiali Chen,Zhen-Feng Wu,Yinghai Jiang,Han Li,Hao Zeng,Pan Wang,Xunjie Feng,Siyu Chen,Binbin Yang,Hongping Jin,Kun He,Junwei Han +28 more
TL;DR: The combination of PD-1 inhibitors with anti-angiogenic therapy and IMRT for HCC is a promising regimen and no significant difference was observed in the treatment-related adverse events between the two groups.
External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Han Li,Zhen-Feng Wu,Jiali Chen,Ke Su,Lu Guo,Ke Xu,T. Gu,Yi Jiang,Pan Wang,Hao Zeng,Hao Chi,Kun He,Junwei Han +12 more
TL;DR: In this article , a meta-analysis aimed to compare efficacy of three combination strategies in treatment of advanced unresectable HCC with a view of guiding future selection of the best combination therapy for sorafenib and local therapy.
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
Ke Su,Yanlin Liu,Pan Wang,Kun He,Fei Wang,Hao Chi,Mingyue Rao,Xueting Li,Lian Xiao Wen,Yanqiong Song,Jianwen Zhang,Tao Gu,K. Xu,Qi Li,Jiali Chen,Zhen-Feng Wu,Han Li,Weihong Huang,Lan Chen,Jian Tong,Hongyan Li,Xunjie Feng,Siyu Chen,Binbin Yang,Hongping Jin,Yue Yang,Huan Liu,Chao Yang,Ming Wu,Fangyu Xiong,Keyi Peng,Lechuan Zhu,Yaoyang Xu,Zunyuan Tan,Xiaotong Luo,Hanyue Zheng,Yuxin Zhang,Lu Guo,Junwei Han +38 more
TL;DR: In this article , the authors evaluated the effect of plasma heat-shock protein 90α (HSP90α) levels on hepatocellular carcinoma (HCC) prognosis.
Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Ke Su,Weihong Huang,Xueting Li,Ke Xu,T. Gu,Yanlin Liu,Juan Song,Keyi Qian,Yaoyang Xu,Hao Zeng,Yipei Yang,Lu Guo,Junwei Han +12 more
TL;DR: In this article , the potential predictive value of both plasma alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) in patients with HCC and to develop a nomogram to assess the prognosis of HCC was investigated.
24
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: a large, multicenter study.
Ke Su,Qiuni Shen,Jian Tong,T. Gu,Ke Xu,Han Li,Hao Chi,Yanlin Liu,Xueting Li,Lian Xiao Wen,Yan-Hong Song,Qu-Lian Guo,Jiali Chen,Zhen-Feng Wu,Ying Jiang,Kun He,Lu Guo,Junwei Han +17 more
TL;DR: In this article , a new nomogram was constructed to predict 1-, 2-, and 3-year survival rates for hepatitis B virus-related hepatocellular carcinoma (HCC) patients.
24